Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
NCT05917106 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450
Last updated 2025-12-11
Summary
To conduct prospective studies to confirm the value of circulating tumor DNA and its abnormal methylation in longitudinal monitoring of patients undergoing kidney cancer surgery.
Conditions
- Carcinoma
- Renal Cell Carcinoma
- RCC
- Kidney Neoplasms
- Kidney Cancer
Sponsors & Collaborators
-
Jinling Hospital, China
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-26
- Primary Completion
- 2028-06-30
- Completion
- 2030-06-30
Countries
- China
Study Locations
More Related Trials
-
Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis
NCT03868215 ·Status: UNKNOWN
-
Comparison of Immune Response Following Surgical Management of Renal Tumors
NCT00289146 ·Status: TERMINATED
-
Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes
NCT05534854 ·Status: UNKNOWN
-
Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma
NCT06912672 ·Status: NOT_YET_RECRUITING
-
ctDNA Methylation Sequencing for Myeloma
NCT05578625 ·Status: UNKNOWN
-
Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)
NCT05116579 ·Status: RECRUITING
-
Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.
NCT03155451 ·Status: COMPLETED
-
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
NCT05366881 ·Status: RECRUITING
-
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors
NCT03596593 ·Status: UNKNOWN ·Phase: NA
-
ctDNA-MRD Monitoring After Resection in Gastric Cancer
NCT06893133 ·Status: RECRUITING
-
Cell-free DNA Methylation Markers for Cancer Screening
NCT03096938 ·Status: UNKNOWN ·Phase: NA
-
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
NCT05112627 ·Status: COMPLETED
-
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
NCT05685524 ·Status: UNKNOWN
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
NCT04835675 ·Status: COMPLETED
-
Multi Institutional Study in Patient Presenting With Hematuria
NCT03122964 ·Status: UNKNOWN
-
Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
NCT05285579 ·Status: UNKNOWN
-
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
NCT04197414 ·Status: RECRUITING
-
Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells
NCT06194669 ·Status: RECRUITING
-
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
NCT05343832 ·Status: UNKNOWN
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
NCT00908739 ·Status: WITHDRAWN
-
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA
NCT05668910 ·Status: UNKNOWN
-
Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary Tumors.
NCT05634655 ·Status: UNKNOWN
-
ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
NCT05630131 ·Status: COMPLETED
-
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
NCT05208372 ·Status: UNKNOWN